ANN ARBOR, Mich., May 12, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”) announces that Company is preparing to transfer production back to Prodigy Textiles, its Vietnamese subsidiary.  During the COVID-19 lockdown, when the Company opted to furlough its non-essential staff, the Company shifted its spider silk production operations focus to its US research facility.  The Company is now ready to transition the majority of its production back to Vietnam as soon as the silkworm rearing cycle allows.

During this pandemic, the Company has continued to advance and strengthen its production operations.  Through vigorous testing of its Dragon Silk^TM and Monster Silk® lines, the Company identified its best performing and hardy silkworms ideally suited for large scale production. This milestone is the result of a dedicated effort by its U.S. staff, going far beyond standard material performance testing.  This first production cycle of 2020, at the Company’s Vietnam factory, will utilize these top performing transgenics, forming a solid foundation for the continued 2020 production scale up.

The Company anticipates rapid scale up of its recombinant spider silk and will use this year’s first production run to ship materials are dedicated to fulfill an outstanding order, by one of the Company development partners. The following production runs will be to address fiber requests made by additional potential development partners and to grow the breeding population.

“As we finish preparations for the 2020 production season, the future of Kraig Labs, has never looked brighter,” said COO Jon Rice.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news   

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

ANN ARBOR, Mich., April 16, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk based fibers, announced, at a press conference held after today’s market close, that it successfully developed a new technology platform, based on a non-CRISPR gene editing knock-in knock-out technology. Other than the silkworm’s remaining specifically desired native silk protein elements, the Company is now able to produce nearly pure spider silk.

The new technology has a purity rate that is about ten times greater than Dragon Silk, a fiber that the Company developed with its previous tools. Dragon Silk has already demonstrated to be tougher than many fibers used in bullet proof vests and the Company expects that the increased spider silk purity, created using this new approach, will yield materials beyond those capabilities.

This new system utilizes the Company’s eco-friendly and cost effective silkworm production system, which is significantly more advanced than any of the competing methods.

Press Conference highlights include:

• Generation II Spider Silk Technology- Essentially pure spider silk.
• Generation III Spider Silk Technology- More specific customization.
• The Company’s knock-in knock-out technology allows Kraig Labs to work with very complex protein sequences in silkworm, which are about four times more complex than published technologies.
• Dr. Trevor Kane, the Company’s Chief Scientific Officer, stated that his team is already working on producing even larger, more complex, constructs, based on the Darwin’s bark spider.  
• Ambitious immunity boosting program will benefit not only the Company’s proprietary transgenics, but will help strengthen production for the mundane silk market, which is a $5 billion a year industry.
• The New Technology, which is the result of over ten years of effort, hits the target of one of the Company’s primary technological goals and opens the door for large scale US production.

This new technology has applications and implications far beyond material performance. The Company is now well underway, and rapidly advancing, its efforts to enhance its silkworm technology to allow for large scale US production. The Company has already begun the validation process for the first of these new transgenics and anticipates US production to be possible as early as 2022 or 2023.

Interested parties are invited to view the press conference rebroadcast at https://youtu.be/NPg_7ACrBjI 

This ground breaking announcement does not affect the Company’s current work, at its overseas production facility, to ramp up Dragon Silk and Monster Silk, as these fibers are designed to address their own markets.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

ANN ARBOR, Mich., April 16, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces the Company will an online press conference, today at 4:30 p.m. Eastern Time, to introduce a game changing Spider Silk technological breakthrough.  This conference will open to all press, stakeholders and interested parties, via a live streaming broadcast at www.kblbinvestors.com/live.

The webcast will be accessible on most operating systems and browsers and a replay will be available, following the event, within the Investor Relations section of the Company’s web site.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

ANN ARBOR, Mich., April 13, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), the leading developer of spider silk based fibers, announces that Kim Thompson, the Company’s CEO and Founder, and Kenneth Le, the President of Prodigy Textiles, will be making a personal donation, on behalf of all Kraig and Prodigy Employees, to the community of Quang Nam Province Vietnam.  Quang Nam is where the Company maintains a production facility and where most of the employees of Prodigy, Kraig’s wholly owned subsidiary, reside. The financial gift is being made in light of the global financial and public health issues facing our world. 

Through this donation, direct food aid will be provided to roughly 600 families in the farming cooperatives and villages in Quang Nam.  Each family will receive 10kg of rice, noodles, cooking oil, fish sauce, and other items.  Additional financial aid being provided will be coordinated by Mr. Le, in partnership with local officials, to ensure that other critical needs in the community are met.

In mid-March the Company took the voluntary step to furlough non-essential workers, as a precautionary step.  To minimize the financial impact of this decision, on furloughed staff, Company management has committed to keep these workers on the payroll through at least the end of April.  Today’s announcement is a further expansion of the Company’s commitment to our team members and their communities.

“I am thankful for the opportunity to personally support our valued team members,” said Thompson.  “As we all work together to combat coronavirus, our team at Kraig Labs continues to make significant progress in critical aspects of our business model.  Having laid a solid foundation, our teams in the US and Vietnam are preparing the Company to exit this stronger than ever.   I believe that this will be a break out year for Kraig Labs, so the least our management team can do is share a little of that good fortune and spread it forward to the communities that are our home.  I want to thank Mr. Ken Le for his generosity, his bold vision and his friendship.  These monies will not come from the corporate treasury.”

“Later this week we will be revealing a major research and development milestone from within our own laboratories,” continued Thompson.  “We view this breakthrough as the most significant and impactful development in our laboratories in more than seven years.  Our scientists are working tirelessly in our pursuit of commercializing nature’s toughest fibers, spider silk. I encourage those who are interested to join us for this live event.”

On April 16 at 4:30pm ET, the Company will be revealing a significant scientific breakthrough in spider silk technology during an online press conference.  All interested parties can view this live event by going to www.kblbinvestors.com

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com 

ANN ARBOR, Mich., April 06, 2020 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), the leading developer of spider silk based fibers, announces that Kim Thompson, the Company’s CEO and Founder, has accepted an invitation to speak at this year’s SynBio Markets conference to be held in Amsterdam, Netherlands beginning November 3^rd.

SynBio Markets focus is synthetic biology solutions to commercial and sustainability challenges.  The international conference is designed to showcase the most innovative synthetic biology companies.

“We are delighted to be welcoming Mr. Thompson to the conference and have such a leader in innovation as Kraig Biocraft Laboratories joining the speaker lineup in Amsterdam. Building on the successful launch event in 2019 we will once again be connecting synbio investors, academics and innovators to commercial end market customers across a variety of verticals. Across three days it will link science and technology to business and is committed to turning potential into reality and building a better, green world,” said Luke Upton, Editor and Co-Founder of SynBio Markets.

This event brings together stakeholders from across all facets of commercial biotechnology, blending innovators and academia with investors and commercial end market customers.  Thompson will be joining an impressive lineup of industry leaders to discuss the commercial opportunities and potential of synthetic biology to reshape and strengthen economies and commercial relationships.

“I am honored to have been selected by SynBio Markets,” said Thompson.  “I look forward to the opportunity to share Kraig Labs’ vision and insight on how our technology, and the technological innovations of others in this field, will change the commercial landscape with powerful products and environmentally friendly production methods.  We are one of the early innovators in this field and we are proud to have plowed a road which other companies are now following.  I want to thank the entire SynBio Markets team for their leadership in organizing this important event.”

To learn more about this important event in the commercialization of leading edge biotechnology, please visit www.synbiomarkets.com

On April 16 at 4:30pm ET, the Company will be revealing a significant scientific breakthrough in spider silk technology during an online press conference.  All interested parties can view this live event by going to www.kblbinvestors.com

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), the leading developer of spider silk based fibers, announces that the Company will be keeping its entire staff on the payroll while its CEO forgoes pay. This decision was made to confirm the Company’s commitment to its staff and to provide support for all of our team members as the coronavirus pandemic continues to impact the globe.

All non-essential staff that were furloughed in the Company’s efforts to limit the spread of COVID-19 will continue to receive their pay. To offset these expenses, Kim Thompson, the Company’s CEO and Founder, has elected to forgo receiving or accruing his salary for the duration of the furlough.

“Kraig Labs is in one of the strongest positions we’ve ever been in, so we are ready to weather the impacts of COVID-19 and come out on the other side stronger. Our teams, in the US and in Vietnam, are the heart of our Company and we are committed to keeping those teams strong and ready,” said Thompson. “Advancements in our commercialization efforts give me confidence that the future for Kraig Labs is brighter than it has ever been.”

Operations at the Company’s US based R&D center continue to break new ground in the field of spider silk genetics in spite of the spread of COVID-19. On April 16 at 4:30 pm ET, the Company will reveal a significant scientific breakthrough in spider silk technology during its online press conference. All interested parties can view this live event by going to www.kblbinvestors.com.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces that it will unveil a new, disruptive spider silk science breakthrough at an online press conference hosted by the Company.

The live webcast will take place on April 16 at 4:30 p.m. Eastern Time and all members of the media, stakeholders and interested parties will be able to view the online broadcast on the Company web site at www.kblbinvestors.com by navigating to “Webcasts”.

Media members who are interested in attending the online unveiling, or scheduling an interview with the Kraig Labs management team, are invited to contact ir@kraiglabs.com.

“We look forward to unveiling this significant achievement of our research and development team and we are very excited to share our having reached a major milestone and longstanding goal of our R&D operation. We believe that we can leverage this new technology for future scientific and business developments,” said CEO and Founder, Kim Thompson.

The webcast will be accessible on most operating systems and browsers. A webcast replay will be available, following the event, within the Investor Relations section of the Company’s web site. The press conference was delayed due to coronavirus and will now take place on April 16.

The Company will publish a follow up release, just prior to the webcast, that will contain viewing details and interested parties are invited to sign up at www.kblbinvestors.com to receive an event reminder with viewing instructions.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward-Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces that beginning today, it is furloughing all non-essential staff until at least April 1, 2020, due to concerns regarding the spread of COVID-19. The implementation of these furloughs is in line with the leading health officials’ guidelines to help slow down the spread of coronavirus and to protect the health and safety of our staff. The Company is not currently aware of any member of its team being personally affected by COVID-19.

The Company does not take this step lightly and believes it to be necessary to address the emerging and ongoing challenge that the COVID-19 outbreak represents globally. This decision was made in an abundance of caution and will primarily impact staff at our fully owned subsidiary, Prodigy Textiles, in Vietnam and will result in the temporary closing of silk rearing operations at that facility. The Company plans to take additional measures to limit the financial impact to its furloughed staff.

Based on a recent commercial silk test production run, completed earlier this month, at the Vietnamese facility, the Company believes it will be well positioned to relaunch commercial production of its ecofriendly high-performance fibers.

Operations and progress at the Company’s research headquarters in the US will be largely unaffected by this decision. The Company and its management have issued guidelines to its US team and implemented additional sterilization and social distancing protocols to minimize the impact of this unprecedented global event.

“The health and safety of our team is our top priority,” said CEO and Founder, Kim Thompson. “Beyond the moral obligation we have to our team, I believe that prioritizing their safety today will ensure a stronger future for our staff, our products and the Company. Our thoughts and prayers are for those around the world who have been personally effected by this disease as we all work together to combat its spread.”

Thompson has decided not to collect nor accrue any salary while the Company has a significant number of staff on furlough.

Kraig Labs encourages everyone to follow the guidelines outlined by our leading health officials in maintaining social distancing in order to prevent the unnecessary spread of COVID-19.

The Company would like to remind all interested parties that it has scheduled an upcoming press conference to announce a major scientific breakthrough in spider silk technology. The live webcast will take place on April 16 at 4:30 p.m. Eastern Time and will be broadcast on the Company website at www.kblbinvestors.com by navigating to “Webcasts”.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces the rescheduling of the upcoming press conference. The Company’s operations have not been directly affected by COVID-19. To ensure continued safe operations for our staff and facility, the Kraig Labs research center will not be hosting any outside visitors for the next 30 days.

The Company will be introducing a game changing Spider Silk technological breakthrough during the upcoming online press conference. This conference will open to all press, stakeholders and interested parties via streaming on the Company’s website. The live webcast is now scheduled to take place on April 16 at 4:30 p.m. Eastern Time and will be broadcast on the Company website at www.kblbinvestors.com by navigating to “Webcasts”.

“While we’re eager to share this exciting scientific breakthrough, we decided, in light of the current COVID-19 situation, to reschedule the press conference. We are taking this obvious step in consideration of the continued good health of our staff and our Nation’s focus on aggressively addressing efforts to combat COVID-19. We are continuing to advance the business model and look forward to providing future updates on that progress,” said CEO and Founder Kim Thompson. “We are excited to unveil our latest breakthrough at the upcoming press conference on April 16^th.”

The webcast will be accessible on most operating systems and browsers. A webcast replay will be available, following the event, within the Investor Relations section of the Company’s web site.

The Company will publish a follow up release, just prior to the webcast, that will contain viewing details and interested parties are invited to sign up at www.kblbinvestors.com to receive an event reminder with viewing instructions.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”), the leading developer of spider silk based fibers, announces that management will host an online presentation to introduce a game changing Spider Silk technological breakthrough.

The online press conference is open to all press, stakeholders and interested parties. The live webcast will take place on March 19 at 4:30 p.m. Eastern Time and will be broadcast on the Company website at www.kblbinvestors.com by navigating to “Webcasts.”

The webcast will be accessible on most operating systems and browsers. A webcast replay will be available, following the event, within the Investor Relations section of the Company’s web site.

The Company will publish a follow up release, just prior to the webcast, that will contain viewing details and interested parties are invited to sign up at www.kblbinvestors.com to receive an event reminder with viewing instructions.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.